The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless merchandise represents a substantial regulatory problem to the FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is thought to work as a sedative at significant dosages6. The promises prod